GlassScriptPhysician profile
Treva Latresse Jones
NPI 1134488851
$1,635.27
in general payments reported to CMS, 2019-2025
17 companies · $69.81 in 2025
The $69.81 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $112 · 2021: $23.73 · 2022: $289 · 2023: $143 · 2024: $834 · 2025: $69.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843 · Travel and Lodging: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.35 |
| Travel and Lodging | $203.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $486.48 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $232.26 | 2020-2024 | Farxiga, Lokelma |
| Janssen Pharmaceuticals, INC | $222.07 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $193.00 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $84.27 | 2022-2023 | Camzyos |
| Abbvie INC. | $64.13 | 2022-2024 | |
| Pfizer INC. | $48.74 | 2024 | |
| Merck Sharp & Dohme LLC | $46.73 | 2024-2025 | Verquvo |
| Aimmune Therapeutics, INC. | $43.39 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.87 | 2024-2025 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $39.53 | 2022-2023 | Ultomiris |
| Lexicon Pharmaceuticals, INC. | $35.78 | 2024 | |
| Edwards Lifesciences Corporation | $23.73 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.42 | 2025 | |
| Jazz Pharmaceuticals INC. | $20.24 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.40 | 2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Treva Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.